Financial giants have made a conspicuous bearish move on AbbVie. Our analysis of options history for AbbVie ABBV revealed 12 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $348,728, and 9 were calls, valued at $438,076.
Expected Price Movements
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $200.0 for AbbVie over the recent three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for AbbVie's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale activity within a strike price range from $90.0 to $200.0 in the last 30 days.
AbbVie Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| ABBV | PUT | TRADE | BULLISH | 03/15/24 | $175.00 | $241.5K | 48 | 718 |
| ABBV | CALL | SWEEP | BEARISH | 06/20/25 | $170.00 | $136.6K | 214 | 70 |
| ABBV | PUT | SWEEP | NEUTRAL | 01/17/25 | $170.00 | $71.4K | 1.6K | 69 |
| ABBV | CALL | SWEEP | BEARISH | 02/16/24 | $160.00 | $63.6K | 3.9K | 63 |
| ABBV | CALL | TRADE | BEARISH | 01/17/25 | $90.00 | $42.9K | 0 | 5 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
In light of the recent options history for AbbVie, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of AbbVie
- With a volume of 2,124,222, the price of ABBV is up 0.51% at $174.17.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 78 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
